W 315 (Clopidogrel bisulfate 300 mg (base))

Pill imprint W 315 has been identified as Clopidogrel bisulfate 300 mg (base).

Clopidogrel is used in the treatment of ischemic stroke; peripheral arterial disease; heart attack; transient ischemic attack; ischemic stroke, prophylaxis (and more), and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Clopidogrel 300 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Clopidogrel bisulfate

Imprint:

W 315

Strength:

300 mg (base)

Color:

Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Platelet aggregation inhibitors

Pregnancy Category:

B - No proven risk in humans

CSA Schedule:

Not a controlled drug

Manufacturer:

Wockhardt Limited

National Drug Code (NDC):

64679-0315

Inactive Ingredients:

microcrystalline cellulose
ferric oxide red
glyceryl dibehenate
hydrogenated castor oil
hydroxypropyl cellulose
hypromellose 2910 (15 mPa.s)
lactose monohydrate
mannitol
polyethylene glycol 6000
titanium dioxide
triacetin

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.